Page 51 - 中国药房2021年11期
P. 51

Foretinib衍生物LWK-126在不同种属肝微粒体中的代谢稳定性

        研究     Δ


                                                         2 #
                                                 2
                                        2
                                2
              1*
        王忠元 ,杨华丽 ,崔 杏 ,朱高峰 ,汤 磊 ,廖伟科 (1.贵州省人民医院药剂科,贵阳 550002;2.贵州省化
                        1
        学合成药物研发利用工程技术研究中心,贵阳 550004)
        中图分类号 969.1;R917         文献标志码 A          文章编号     1001-0408(2021)11-1325-05
        DOI  10.6039/j.issn.1001-0408.2021.11.08
        摘  要   目的:建立测定肝微粒体中Foretinib衍生物LWK-126质量浓度的方法,研究其在大鼠、比格犬、人肝微粒体中的代谢稳
        定性。方法:采用体外肝微粒体孵育体系,将LWK-126分别溶于由还原型烟酰胺腺嘌呤二核苷酸磷酸溶液启动的大鼠、比格犬、
        人肝微粒体孵育体系中,于37 ℃水浴下分别孵育0、5、10、20、30、60 min时加入含内标(1 μg/mL甲苯磺丁脲)的乙腈终止反应,并
        采用超高效液相色谱-串联质谱法检测各孵育体系中LWK-126的质量浓度。以Waters BEH C18为色谱柱,以水(含0.01%甲酸)-乙
        腈(含0.01%甲酸)为流动相进行梯度洗脱,流速为0.4 mL/min,柱温为30 ℃,进样量为2 μL;离子源为电喷雾电离源,采用正离子
        模式采集,扫描范围为m/z 50→1 200。以孵育0 min时LWK-126的质量浓度为参照,计算其在不同孵育体系中的剩余百分率与酶
                                                                    2
        动力学参数。结果:LWK-126检测质量浓度的线性范围为0.05~15 μg/mL(R =0.999 2),定量下限为0.05 μg/mL,最低检测限为
        0.01 μg/mL,精密度、准确度、提取回收率和基质效应均符合生物样品定量分析的要求。LWK-126在人、大鼠、比格犬肝微粒体中
        孵育60 min后的剩余百分率分别为(33.17±4.52)%、(3.14±6.73)%、(1.38±5.85)%,半衰期分别为33.15、11.76、5.62 min,清除
        率分别为38.45、118.81、245.76 μL/(min·mg)。结论:成功建立了肝微粒体中LWK-126质量浓度的测定方法。LWK-126在不同种
        属肝微粒体中的代谢稳定性排序依次为人>大鼠>比格犬。
        关键词 LWK-126;超高效液相色谱-串联质谱法;肝微粒体;代谢稳定性

        Study on Metabolic Stability of Foretinib Derivative LWK-126 in Liver Microsomes of Different Species
                                                              2
                        1
                                                2
                                     1
                                                                         2
        WANG Zhongyuan ,YANG Huali ,CUI Xing ,ZHU Gaofeng ,TANG Lei ,LIAO Weike(1. Dept. of Pharmacy,
                                                                                      2
        Guizhou Provincial People’s Hospital,Guiyang 550004,China;2. Guizhou Provincial Engineering Technology
        Research Center for Chemical Drug R&D,Guiyang 550004,China)
        ABSTRACT    OBJECTIVE:To establish the method for the concentration determination of foretinib derivative LWK-126 in liver
        microsomes,and to study its metabolism stability in liver microsomes of rats,Beagle dogs and human. METHODS:In the in vitro
        incubation system of liver microsomes,LWK-126 was dissolved in liver microsomal incubation systems of rats,Beagle dog and
        human initiated by reduced nicotinamide adenine dinucleotide phosphate solution. After incubation in water at 37 ℃ for 0,5,10,20,
        30 and 60 min,the reaction was terminated with acetonitrile containing internal standard(1 μg/mL tolbutamide). UPLC-MS/MS
        method was applied to determine the concentration of LWK-126 in the incubation systems. The determination was performed on
        Waters BEH C18 column with mobile phase consisted of water(containing 0.1% formic acid)-acetonitrile(containing 0.1% formic
        acid)by gradient elution at the flow rate of 0.4 mL/min. The column temperature was 30 ℃,and the sample size was 2 μL. The
        mass spectral analysis was performed in a positive electrospray ionization mode,and the full MS experiment was run with the
        selective reaction monitoring mode with a scanning range of m/z 50→1 200. Taking the concentration of LWK-126 at 0 min as
        reference,the remaining percentage and the enzyme kinetic parameters were calculated. RESULTS:The linear range of LWK-126
                          2
        was 0.05-15 μg/mL(R =0.999 2);the lower limit of quantification was 0.05 μg/mL,and the lowest detection limit was 0.01
        μg/mL. The precision,accuracy,extraction recovery and matrix effect all met the analysis requirements of biological samples. The
        remaining percentage of LWK-126 in liver microsomes of human,rats and Beagle dogs for 60 min were(33.17±4.52)%,(3.14±
        6.73)%,(1.38±5.85)%;t 1/2 of them were 33.15,11.76,5.62 min;the clearance rates were 38.45,118.81,245.76 μL/(min·mg),
                                                           respectively. CONCLUSIONS: The method for the content
           Δ 基金项目:国家自然科学基金青年科学基金项目(No.81903472);           determination of LWK-126 in liver microsomes is established
        贵州省高层次创新型人才-百层次人才项目(No.黔科合平台人才
                                                           successfully. The order of metabolic stability of LWK-126 in
       〔2016〕4015)                                         liver microsomes of different species is human>rats>Beagle
           *主管药师,硕士。研究方向:药物分析、医院药学。E-mail:
                                                           dogs.
        154366202@qq.com
           # 通信作者:副教授,博士。研究方向:创新药物。电话:0851-                KEYWORDS     LWK-126;UPLC-MS/MS;Liver microsomes;
        86908318。E-mail:641212891@qq.com                   Metabolic stability


        中国药房    2021年第32卷第11期                                             China Pharmacy 2021 Vol. 32 No. 11  ·1325 ·
   46   47   48   49   50   51   52   53   54   55   56